Sacubitril/valsartan in the treatment of systemic right ventricular failure

OBJECTIVE: Pharmacological options for patients with a failing systemic right ventricle (RV) in the context of transposition of the great arteries (TGA) after atrial switch or congenitally corrected TGA (ccTGA) are not well defined. This study aims to investigate the feasibility and effects of sacub...

Descripción completa

Detalles Bibliográficos
Autores principales: Zandstra, Tjitske E, Nederend, Marieke, Jongbloed, Monique R M, Kiès, Philippine, Vliegen, Hubert W, Bouma, Berto J, Tops, Laurens F, Schalij, Martin J, Egorova, Anastasia D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Congenital Heart Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522462/
https://www.ncbi.nlm.nih.gov/pubmed/33452121
http://dx.doi.org/10.1136/heartjnl-2020-318074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522462/
https://www.ncbi.nlm.nih.gov/pubmed/33452121
http://dx.doi.org/10.1136/heartjnl-2020-318074

Ejemplares similares